Related references
Note: Only part of the references are listed.Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
Casey M. Theriot et al.
NATURE COMMUNICATIONS (2014)
Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection
Casey M. Theriot et al.
GUT MICROBES (2014)
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Christian Quast et al.
NUCLEIC ACIDS RESEARCH (2013)
Gut Microbiota Patterns Associated with Colonization of Different Clostridium difficile Ribotypes
Jure Skraban et al.
PLOS ONE (2013)
High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria
Matthew J. Hamilton et al.
GUT MICROBES (2013)
Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis
Charlie G. Buffie et al.
INFECTION AND IMMUNITY (2012)
Clostridium difficile Carriage in Elderly Subjects and Associated Changes in the Intestinal Microbiota
Mary C. Rea et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice
Trevor D. Lawley et al.
PLOS PATHOGENS (2012)
Tigecycline Exhibits Inhibitory Activity against Clostridium difficile in the Colon of Mice and Does Not Promote Growth or Toxin Production
Robin L. P. Jump et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In Vitro and In Vivo Intracellular Killing Effects of Tigecycline against Clinical Nontyphoid Salmonella Isolates Using Ceftriaxone as a Comparator
Hung-Jen Tang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
UCHIME improves sensitivity and speed of chimera detection
Robert C. Edgar et al.
BIOINFORMATICS (2011)
Reducing the Effects of PCR Amplification and Sequencing Artifacts on 16S rRNA-Based Studies
Patrick D. Schloss et al.
PLOS ONE (2011)
Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia
Mary Townsend et al.
Infection and Drug Resistance (2011)
The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection
Angela E. Reeves et al.
GUT MICROBES (2011)
Activity of tigecycline against recent European clinical isolates of Clostridium difficile
Stephen P. Hawser
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole
Ching-Lan Lu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Comparative Metagenomic Study of Alterations to the Intestinal Microbiota and Risk of Nosocomial Clostridum difficile-Associated Disease
Amee R. Manges et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities
Patrick D. Schloss et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2009)
Intravenous Tigecycline as Adjunctive or Alternative Therapy for Severe Refractory Clostridium difficile Infection
Bjorn L. Herpers et al.
CLINICAL INFECTIOUS DISEASES (2009)
Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation
Dionysios A. Antonopoulos et al.
INFECTION AND IMMUNITY (2009)
Accurate determination of microbial diversity from 454 pyrosequencing data
Christopher Quince et al.
NATURE METHODS (2009)
A High-Throughput DNA Sequence Aligner for Microbial Ecology Studies
Patrick D. Schloss
PLOS ONE (2009)
Case-control study of antibiotic use and subsequent Clostridium difficile - Associated diarrhea in hospitalized patients
Roger Baxter et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea
Ju Young Chang et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy
Qiong Wang et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
In vitro activities of 15 antimicrobial agents against 110 toxigenic Clostridium difficile clinical isolates collected from 1983 to 2004
David W. Hecht et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Risk factors for Clostridium difficile-associated diarrhea on an adult hematology-oncology ward
A. H. Gifford et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model
Simon D. Baines et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Effect of tigecycline on normal oropharyngeal and intestinal microflora
Carl Erik Nord et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea:: A cohort study during an epidemic in Quebec
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2005)
Efficacy of tigecycline in complicated skin and skin structure infections and complicated intra-abdominal infections
MH Wilcox
JOURNAL OF CHEMOTHERAPY (2005)
A similarity measure based on species proportions
JC Yue et al.
COMMUNICATIONS IN STATISTICS-THEORY AND METHODS (2005)
The Ribosomal Database Project (RDP-II): sequences and tools for high-throughput rRNA analysis
JR Cole et al.
NUCLEIC ACIDS RESEARCH (2005)
In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens
PJ Petersen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection
MJ Hopkins et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2002)
Share Paper
